A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B

Launched by ADDPHARMA INC. · May 29, 2024

Keywords

ClinConnect Summary

This clinical trial is testing a combination of two medications, AD-227A and AD-227B, to see how well they work together in treating essential hypertension, which is high blood pressure without a known cause. The study aims to determine if this combination is both effective and safe for patients. They are currently looking for participants, and anyone aged 18 or older who has been diagnosed with essential hypertension may be eligible to join.

To participate, individuals must sign a consent form agreeing to take part in the study. However, people with secondary hypertension, which is high blood pressure caused by another health issue, won't be able to join. If you choose to participate, you can expect to receive the medications and be monitored by healthcare professionals throughout the trial to ensure your safety and to assess how well the treatment is working. This study is a great opportunity for those looking to contribute to research that may help improve hypertension treatment in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Signed informed consent
• • Patients with Essential Hypertension
• • Other inclusions applied
• Exclusion Criteria:
• • Patient with Secondary Hypertension
• • Other exclusions applied

Trial Officials